Top Story

NIAID awards grant for hospital-acquired infection vaccine research

September 21, 2014

The National Institute of Allergy and Infectious Diseases awarded the Los Angeles Biomedical Research Institute a $1.3 million grant toward research and development of a vaccine targeting candidiasis and MRSA, according to a press release.

The 4-year grant was awarded to John E. Edwards, MD, and Ashraf S. Ibrahim, PhD, both of the Los Angeles Biomedical Research Institute (LA BioMed), and will fund an ongoing clinical trial assessing the efficacy of a vaccine to protect patients from candidiasis.

figure Meeting News CoverageVideo

Robust antibiotic pipeline may require new thinking

September 20, 2014
WASHINGTON, D.C. — ICAAC 2014 keynote speaker John H. Rex, MD, senior vice president and head of infection, global medicines development at AstraZeneca, reviews…
Perspective

CDC: Enterovirus D68 continues to spread across US

September 19, 2014
The CDC has confirmed that enterovirus D68 has spread to 22 states, including the West Coast, infecting 160 people.Alabama, California, Colorado, Connecticut, Georgia…

NIH director: Emerging biomedical research ‘breathtaking’

September 19, 2014
NIH director Francis Collins, MD, PhD, spoke to the audience at TEDMED 2014 about the advances in biomedical research on the horizon.“I have this amazing…
More News Headlines »
Cover Story
figure

The Challenge of Genotype 3

HCV Next, September 2014
For many clinicians, genotype 3 now presents the greatest challenge in the treatment and management of patients with…
More »
Blog

Updates to adult immunization schedule

January 30, 2013
Each year in January, the CDC publishes an adult immunization schedule, updating information relating to the vaccines…
More »
Meeting News Coverage Video
figure

Robust antibiotic pipeline may require new thinking

September 20, 2014
WASHINGTON, D.C. — ICAAC 2014 keynote speaker John H. Rex, MD, senior vice president and head of infection…
More »